Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263\u201373.<\/p>\n
CAS<\/a>\u00a0 Ibrahim SH, Hirsova P, Gores GJ. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018;67:963\u201372.<\/p>\n CAS<\/a>\u00a0 Farrell GC, Haczeyni F, Chitturi S. Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv Exp Med Biol. 2018;1061:19\u201344.<\/p>\n CAS<\/a>\u00a0 Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592\u2013609.<\/p>\n PubMed<\/a>\u00a0 Castera L. Noninvasive evaluation of nonalcoholic fatty liver disease. Semin Liver Dis. 2015;35:291\u2013303.<\/p>\n PubMed<\/a>\u00a0 Shen FF, Lu LG. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease. J Dig Dis. 2016;17:565\u201371.<\/p>\n PubMed<\/a>\u00a0 Evans CD, Oien KA, MacSween RN, Mills PR. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol. 2002;55:689\u201392.<\/p>\n CAS<\/a>\u00a0 Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2018;41:372\u201382.<\/p>\n CAS<\/a>\u00a0 Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2018;79:64\u201376.<\/p>\n CAS<\/a>\u00a0 de Meijer VE, Kalish BT, Puder M, Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg. 2010;97:1331\u20139.<\/p>\n PubMed<\/a>\u00a0 Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865\u201373.<\/p>\n CAS<\/a>\u00a0 Koutoukidis DA, Astbury NM, Tudor KE, Morris E, Henry JA, Noreik M, et al. Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern Med. 2019;179:1262\u201371.<\/p>\n PubMed<\/a>\u00a0 Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u201357.<\/p>\n PubMed<\/a>\u00a0 European Association for the Study of the L. European association for the study of D, European association for the study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.<\/p>\n Fan JG, Wei L, Zhuang H. National workshop on fatty L, alcoholic liver disease CSoHCMA, fatty liver disease expert committee CMDA. guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis. 2019;20:163\u201373.<\/p>\n PubMed<\/a>\u00a0 Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008;9:108\u201312.<\/p>\n PubMed<\/a>\u00a0 Chinese Society of Hepatology CMA. [Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]. Zhonghua Gan Zang Bing Za Zhi. 2024;32:418\u201334.<\/p>\n Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2021;160:912\u20138.<\/p>\n Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33:2156\u201363.<\/p>\n PubMed<\/a>\u00a0 Properzi C, O\u2019Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. Ad libitum mediterranean and Low-Fat diets both significantly reduce hepatic steatosis: A randomized controlled trial. Hepatology. 2018;68:1741\u201354.<\/p>\n CAS<\/a>\u00a0 Luo Y, Wang J, Sun L, Gu W, Zong G, Song B, et al. Isocaloric-restricted Mediterranean diet and Chinese diets high or low in plants in adults with prediabetes. J Clin Endocrinol Metab. 2022;107:2216\u201327.<\/p>\n PubMed<\/a>\u00a0 Zhang K, Wu Y, Yi L, Wu Y, Deng Y, Xu X, et al. Adherence to the Mediterranean diet and risk of depression: a cohort study in Chinese community residents. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17060942<\/a><\/p>\n Article<\/a>\u00a0 Hallsworth K, Adams LA. Lifestyle modification in NAFLD\/NASH: facts and figures. JHEP Rep. 2019;1:468\u201379.<\/p>\n PubMed<\/a>\u00a0 Zhang XL, Wang TY, Targher G, Byrne CD, Zheng MH. Lifestyle interventions for non-obese patients both with, and at risk, of non-alcoholic fatty liver disease. Diabetes Metab J. 2022;46:391\u2013401.<\/p>\n PubMed<\/a>\u00a0 Andrade C, Menon V, Ameen S, Kumar Praharaj S. Designing and conducting knowledge, attitude, and practice surveys in psychiatry: practical guidance. Indian J Psychol Med. 2020;42:478\u201381.<\/p>\n PubMed<\/a>\u00a0 World Health Organization. Advocacy, communication and social mobilization for TB control: a guide to developing knowledge, attitude and practice surveys. http:\/\/whqlibdoc.who.int\/publications\/2008\/9789241596176_eng.pdf<\/a>. Accessed 22 Nov\u00a02008.<\/p>\n Roy K, Iyer U, Vaishnav T. Knowledge attitude and practices of type 2 diabetics with ultrasound diagnosed non-alcoholic fatty liver disease. Intl J Curr Res. 2016;8:38540\u20135.<\/p>\n Leung CM, Lai LS, Wong WH, Chan KH, Luk YW, Lai JY, et al. Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol. 2009;24:1786\u201390.<\/p>\n PubMed<\/a>\u00a0 Ghevariya V, Sandar N, Patel K, Ghevariya N, Shah R, Aron J, et al. Knowing what\u2019s out there: awareness of Non-Alcoholic fatty liver disease. Front Med (Lausanne). 2014;1:4.<\/p>\n PubMed<\/a>\u00a0 Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015;49:e6\u201310.<\/p>\n CAS<\/a>\u00a0 Goh GB, Kwan C, Lim SY, Venkatanarasimha NK, Abu-Bakar R, Krishnamoorthy TL, et al. Perceptions of non-alcoholic fatty liver disease – an Asian community-based study. Gastroenterol Rep. 2016;4:131\u20135.<\/p>\n Tincopa MA, Wong J, Fetters M, Lok AS. Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study. BMJ Open Gastroenterol. 2021. https:\/\/doi.org\/10.1136\/bmjgast-2021-000634<\/a>.<\/p>\n Article<\/a>\u00a0 Matthias AT, Fernandopulle ANR, Seneviratne SL. Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study. BMC Res Notes. 2018;11:556.<\/p>\n PubMed<\/a>\u00a0 Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70:1119\u201333.<\/p>\n PubMed<\/a>\u00a0 Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50:204\u201310.<\/p>\n PubMed<\/a>\u00a0 Yip TC, Lee HW, Chan WK, Wong GL, Wong VW. Asian perspective on NAFLD-associated HCC. J Hepatol. 2022;76:726\u201334.<\/p>\n CAS<\/a>\u00a0 Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle\/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25:383\u201391.<\/p>\n PubMed<\/a>\u00a0 Han Q, Guo J, Gong L, Liu C, Zhang F. Analysis of the detection rate and related factors of fatty liver disease in physical examination of healthy population in Chengdu district. Medicine. 2023;102:e35087.<\/p>\n CAS<\/a>\u00a0 Miao Y, Wang Y, Yan P, Li Y, Chen Z, Tong N, et al. Association between the fatty liver index (FLI) and incident coronary heart disease: insights from a cohort study on the Chinese population. Front Endocrinol (Lausanne). 2024;15:1367853.<\/p>\n PubMed<\/a>\u00a0 Zhang W, Chao S, Chen S, Rao H, Huang R, Wei L, et al. Awareness and knowledge of nonalcoholic fatty liver disease among office employees in Beijing, China. Dig Dis Sci. 2019;64:708\u201317.<\/p>\n PubMed<\/a>\u00a0 Chen S, Chao S, Konerman M, Zhang W, Rao H, Wu E, et al. Survey of nonalcoholic fatty liver disease knowledge, nutrition, and physical activity patterns among the general public in Beijing, China. Dig Dis Sci. 2019;64:3480\u20138.<\/p>\n PubMed<\/a>\u00a0 Gu Y, Zhou R, Kong T, Zhang W, Chen Y, Wang C, et al. Barriers and enabling factors in weight management of patients with nonalcoholic fatty liver disease: a qualitative study using the COM-B model of behaviour. Health Expect. 2023;26:355\u201365.<\/p>\n PubMed<\/a>\u00a0 Alnuaimi AS, Syed MA, Zainel AA, Mohamed HA, Bougmiza MI, Syed MA. Cultural & region-specific adaptation of KAP (knowledge, attitude, and practice) tool to capture healthy lifestyle within primary care settings. PLoS ONE. 2024;19:e0312852.<\/p>\n CAS<\/a>\u00a0 Zhuang M, Zhai L, Zhang H, Chen Q, Xiong R, Liu Y, et al. Rural residents\u2019 knowledge, attitude, and practice in relation to infection risk during the late stage of an epidemic: a cross-sectional study of COVID-19. Front Public Health. 2024;12:1450744.<\/p>\n PubMed<\/a>\u00a0 Chinese Center for Disease Control and Prevention. Eight key recommendations from Dietary Guidelines for Chinese Residents. Beijing: Chinese Center for Disease Control and Prevention; 2022.<\/p>\n Bloom BS. Learning for Mastery. Instruction and Curriculum. Regional education laboratory for the Carolinas and Virginia, topical papers and Reprints, number 1. Evaluation Comment. 1968;1:n2.<\/p>\n Kline RB. Principles and practice of structural equation modeling (Fifth Edition). New York: The Guilford Press; 2023.<\/p>\n Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739\u201352.<\/p>\n PubMed<\/a>\u00a0 Chen C, Lu FC, Department of Disease Control Ministry of Health PRC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1\u201336.<\/p>\n PubMed<\/a>\u00a0 Li W. Knowledge, attitudes, and practices regarding metabolic associated fatty liver disease (MAFLD) in elderly patients. Sci Rep. 2025;15:17215.<\/p>\n CAS<\/a>\u00a0 Zhang N, Ning W, Xie T, Liu J, He R, Zhu B, et al. Spatial disparities in access to healthcare professionals in Sichuan: evidence from county-level data. Healthcare. 2021. https:\/\/doi.org\/10.3390\/healthcare9081053<\/a>.<\/p>\n Article<\/a>\u00a0 Svendsen MT, Bak CK, Sorensen K, Pelikan J, Riddersholm SJ, Skals RK, et al. Associations of health literacy with socioeconomic position, health risk behavior, and health status: a large National population-based survey among Danish adults. BMC Public Health. 2020;20:565.<\/p>\n PubMed<\/a>\u00a0 Du Y, Ratnapradipa KL, Su D, Dong J, Rochling FA, Farazi PA. Effects of interventions for improving awareness and knowledge of nonalcoholic fatty liver disease among Chinese young adults for prevention of liver cancer-a randomized controlled trial. J Cancer Educ. 2024;39:253\u201363.<\/p>\n PubMed<\/a>\u00a0 Bergen N, Labonte R. Everything is perfect, and we have no problems: detecting and limiting social desirability bias in qualitative research. Qual Health Res. 2020;30:783\u201392.<\/p>\n PubMed<\/a>\u00a0 Latkin CA, Edwards C, Davey-Rothwell MA, Tobin KE. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict Behav. 2017;73:133\u20136.<\/p>\n PubMed<\/a>\u00a0 Hallsworth K, Dombrowski SU, McPherson S, Anstee QM, Avery L. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. Transl Behav Med. 2020;10:1016\u201330.<\/p>\n PubMed<\/a>\u00a0 Haigh L, Bremner S, Houghton D, Henderson E, Avery L, Hardy T, et al. Barriers and facilitators to mediterranean diet adoption by patients with nonalcoholic fatty liver disease in Northern Europe. Clin Gastroenterol Hepatol. 2019;17:1364\u201371. e3.<\/p>\n PubMed<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263\u201373. CAS\u00a0 PubMed\u00a0 Google Scholar\u00a0 Ibrahim SH, Hirsova…\n","protected":false},"author":2,"featured_media":120550,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[76678,6136,74996,76679,6135,4741,3181,163,85,46,3749,6134,12096,10968,546,6137],"class_list":["post-120549","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-attitudes","tag-biostatistics","tag-cross-sectional-study","tag-dietary-management","tag-environmental-health","tag-epidemiology","tag-general","tag-health","tag-il","tag-israel","tag-knowledge","tag-medicine-public-health","tag-non-alcoholic-fatty-liver-disease","tag-practices","tag-public-health","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/120549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=120549"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/120549\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/120550"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=120549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=120549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=120549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}